{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:01:23Z","timestamp":1772794883415,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":676,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/hae.12277","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T12:17:37Z","timestamp":1382703457000},"page":"805-807","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study"],"prefix":"10.1111","volume":"19","author":[{"given":"E.","family":"Berntorp","sequence":"first","affiliation":[{"name":"Centre for Thrombosis and Haemostasis; Sk\u00e5ne University Hospital; Lund University; Malm\u00f6 Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"10.1111\/hae.12277-BIB0001|hae12277-cit-0001","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/hae.12216","article-title":"Pharmacokinetics of plasma-derived and recombinant FIX - implications for prophylaxis and on-demand therapy","volume":"19","author":"Bj\u00f6rkman","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0002|hae12277-cit-0002","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/hae.12188","article-title":"Population pharmacokinetics of recombinant FIX: implications for dose tailoring","volume":"19","author":"Bj\u00f6rkman","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0003|hae12277-cit-0003","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2009.02191.x","article-title":"Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A","volume":"4","author":"Bjorkman","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0004|hae12277-cit-0004","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jth.12055","article-title":"Project on factor VIIIFIXPotFVFIXS standardization committee of the I. Measurement of factor VIII pharmacokinetics in routine clinical practice","volume":"11","author":"Bjorkman","year":"2013","journal-title":"J Throm Haemost"},{"key":"10.1111\/hae.12277-BIB0005|hae12277-cit-0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0006|hae12277-cit-0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2516.2001.00465.x","article-title":"Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis","volume":"7","author":"Bjorkman","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0007|hae12277-cit-0007","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00228-012-1211-z","article-title":"Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis","volume":"68","author":"Bjorkman","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/hae.12277-BIB0008|hae12277-cit-0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2516.2004.01036.x","article-title":"A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia","volume":"10","author":"Ahnstrom","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0009|hae12277-cit-0009","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2516.2003.00762.x","article-title":"The pharmacokinetics of clotting factor therapy","volume":"9","author":"Berntorp","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0010|hae12277-cit-0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1649667","article-title":"Biochemical and in vivo properties of high purity factor IX concentrates","volume":"70","author":"Berntorp","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/hae.12277-BIB0011|hae12277-cit-0011","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00194400","article-title":"Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation","volume":"46","author":"Bjorkman","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/hae.12277-BIB0012|hae12277-cit-0012","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0609.1993.tb00638.x","article-title":"Pharmacokinetic dosing in prophylactic treatment of hemophilia A","volume":"51","author":"Carlsson","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1111\/hae.12277-BIB0013|hae12277-cit-0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2516.1998.00173.x","article-title":"Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis","volume":"4","author":"Carlsson","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0014|hae12277-cit-0014","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2516.2012.02879.x","article-title":"Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy","volume":"18","author":"Lindvall","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/hae.12277-BIB0015|hae12277-cit-0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1538-7836.2009.03703.x","article-title":"Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens","volume":"8","author":"Collins","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/hae.12277-BIB0016|hae12277-cit-0016","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A","volume":"7","author":"Collins","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/hae.12277-BIB0017|hae12277-cit-0017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood-2011-07-360594","article-title":"Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight","volume":"119","author":"Bjorkman","year":"2012","journal-title":"Blood"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhae.12277","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/hae.12277\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T22:33:01Z","timestamp":1716071581000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.12277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1111\/hae.12277","relation":{},"ISSN":["1351-8216"],"issn-type":[{"value":"1351-8216","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,25]]}}}